Tissue Expanders Market Expected to Reach $1.2 Billion by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Tissue Expanders Market," The tissue expanders market size was valued at $671.46 million in 2021, and is estimated to reach $1,180.0 million by 2031, growing at a CAGR of 5.8% from 2022 to 2031. Tissue expanders and accessories are intended for temporary subcutaneous or submuscular implantation to develop surgical flaps or additional tissue coverage in a variety of surgical applications. Tissue expanders are used in various anatomical locations such as breast, head, neck, calf, and others. It is composed of inflatable silicone elastomer outer shell with an injection port. It is available in many different shapes, sizes, volume ranges, dimensions, and surface texture. Tissue expanders also have accessories such as port detectors, fluid dispensing systems, needle infusion sets, and external fill ports or syringe assists.

Factors that drive the growth of the tissue expanders market include rise in number of product launches and product approvals for tissue expanders, increase in number of minimally invasive surgeries for improvement in aesthetic appearance. For instance, in 2020, according to American Society of Plastic Surgery, it was reported that around 137,808 breast reconstruction surgeries were performed in the U.S. Thus, rise in number of breast reconstruction surgeries drives the demand for tissue expanders. Thus, this factor is anticipated to drive the growth of tissue expanders market.

Tissue expanders market trends include the increase in prevelence of breast cancer. According to Breast Cancer. ORG, in 2022, it was reported that, about 13% (about 1 in 8) of U.S. women are going to develop invasive breast cancer in the course of their life. In addition, in 2022, an estimated 287,850 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 51,400 new cases of non-invasive (in situ) breast cancer. Moreover, according to World Health Organization (WHO), in 2020, there were 2.3 million women diagnosed with breast cancer and 685 000 deaths globally. As of the end of 2020, there were 7.8 million women alive who were diagnosed with breast cancer in the past 5 years, making it the world’s most prevalent cancer. Thus, rise in prevalence of breast cancer among female population is anticipated to drive the demand for mastectomy. Moreover, mastectomy is anticipated to boost the demand for tissue expanders for breast reconstruction. Therefore, this factor is anticipated to drive the tissue expanders market growth.

Rise in the awareness among people regarding aesthetic appearance and increase in demand for aesthetic procedures are anticipated to boost the adoption of minimally invasive surgeries. Moreover, rise in number of product approvals for tissue expanders is anticipated to drive the growth of tissue expanders. For instance, in 2022, GC Aesthetics, a medical technology company providing aesthetic and reconstructive solutions, announced the CE approval of the new micro-textured anatomical breast implant LUNA xt. It is the first breast implant in the world approved under the new European Medical Device Regulation (MDR). In addition, rise in the number of adoptions of key strategies such as acquisition, partnership, agreement, and business expansion by tissue expanders industry who manufacture tissue expanders is anticipated to drive the growth of market.

By lesion site, the market is segmented into lower extremity, upper extremity, and others. The others segment dominated the market in 2021 and is expected to continue this trend during the forecast period, owing to rise in the demand of tissue expanders for burn repair, scar repair, and breast reconstruction.

By product shape, the market is classified into rectangular, crescent, round, and others. The rectangular segment dominated the market in 2021 and is expected to continue this trend during the forecast period owing to rise in number of product launch and product approval of rectangular tissue expanders.

By end user, the market is divided into hospitals, cosmetic clinics, and ambulatory surgical centers. The hospitals segment dominated the market in 2021 and is expected to continue this trend during the forecast period owing to rise in expenditure by governments to develop healthcare infrastructure and increase in number of hospitals & clinics.

North America accounted for most of the global tissue expanders market share in 2021 and is anticipated to remain dominant during the forecast period. This is attributed to rise in number of product launch & product approval, increase in number of key players, and developed healthcare infrastructure. Asia-Pacific is anticipated to witness lucrative growth during the forecast period owing to rise in expenditure by government organizations to develop the healthcare sector and increase in awareness regarding minimally invasive procedures.

Key Findings Of The Study

• By lesion site, the others segment was the highest contributor to the market in 2021.
• By product shape, the rectangular segment was the highest contributor to the market in 2021.
• By end user, the hospital segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
• By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period